About 90% of the U.S. population has gotten their two-dose regimen to protect against measles, mumps and rubella, but ...

A new study led by scientists at The Wistar Institute, in collaboration with the University of Pennsylvania Perelman School ...

BRIDGEWATER, NJ, USA I March 14, 2025 I Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug ...

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced its plans to explore utilizing Molecular Envelope Technology (MET) ...

It seeks to promote an interdisciplinary dialogue on innovative strategies, novel vaccine targets, and delivery systems, ultimately highlighting the transformative potential of therapeutic vaccines in ...

The same day, Kennedy appeared on Fox News, saying federal reporting systems for vaccine injuries are insufficient, although adverse reactions are reportable and searchable by the HHS.

Who is most at risk for measles? Unvaccinated children are at risk of getting measles, but so are other people who are not able to get the vaccine or who have compromised immune systems. How does the ...

The COVID-19 vaccine candidate used in the research is by Australian-based vaccine developer Technovalia. The research has been published as an article, 'Skin patch delivery of a SARS-CoV-2 spike DNA ...

Currently, there are several norovirus vaccines in the works ... based company called Vaxart and uses a proprietary oral delivery system. The pill includes a deactivated virus particle (an ...